These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36310439)
1. The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy. Wasala LP; Watkins TB; Wasala NB; Burke MJ; Yue Y; Lai Y; Yao G; Duan D Hum Gene Ther; 2023 May; 34(9-10):459-470. PubMed ID: 36310439 [TBL] [Abstract][Full Text] [Related]
2. Development of Novel Micro-dystrophins with Enhanced Functionality. Ramos JN; Hollinger K; Bengtsson NE; Allen JM; Hauschka SD; Chamberlain JS Mol Ther; 2019 Mar; 27(3):623-635. PubMed ID: 30718090 [TBL] [Abstract][Full Text] [Related]
3. Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model. Wasala NB; Yue Y; Hu B; Shin JH; Srivastava A; Yao G; Duan D Hum Gene Ther; 2023 May; 34(9-10):449-458. PubMed ID: 36515166 [TBL] [Abstract][Full Text] [Related]
4. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function. Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338 [TBL] [Abstract][Full Text] [Related]
5. A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy. Rodino-Klapac LR; Janssen PM; Montgomery CL; Coley BD; Chicoine LG; Clark KR; Mendell JR J Transl Med; 2007 Sep; 5():45. PubMed ID: 17892583 [TBL] [Abstract][Full Text] [Related]
6. Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the Potter RA; Griffin DA; Heller KN; Peterson EL; Clark EK; Mendell JR; Rodino-Klapac LR Hum Gene Ther; 2021 Apr; 32(7-8):375-389. PubMed ID: 33397205 [TBL] [Abstract][Full Text] [Related]